KORU MEDICAL SYSTEMS INC (KRMD) — insider trading
Health Care · NASDAQ
KORU MEDICAL SYSTEMS INC (KRMD) has 31 reported SEC Form 4 insider transactions in our data, including 9 open-market purchases among the most recent 31 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | WHOLIHAN EDWARD | Director | Grant / award / vesting | 5,119 | $2.93 | $15.0K | Form 4 |
| 2026-10-01 | Matin Shahriar | Director | Grant / award / vesting | 5,119 | $2.93 | $15.0K | Form 4 |
| 2026-10-01 | French Donna | Director | Grant / award / vesting | 5,119 | $2.93 | $15.0K | Form 4 |
| 2026-10-01 | FLETCHER R JOHN | Director, Other | Grant / award / vesting | 7,679 | $2.93 | $22.5K | Form 4 |
| 2026-10-01 | CASCELLA ROBERT | Director | Grant / award / vesting | 5,119 | $2.93 | $15.0K | Form 4 |
| 2026-09-30 | Manko Joseph M. Jr.; Horton Capital Management, LLC; Horton Capital Partners, LLC; Horton Capital Partners Fund, L.P. | Director, 10% owner | Grant / award / vesting | 5,119 | — | $0 | Form 4 |
| 2026-09-08 | KALBERMATTEN ADAM R | Officer (Chief Commercial Officer) | Open-market purchase | 32,000 | $3.16 | $101.1K | Form 4 |
| 2026-07-28 | KALBERMATTEN ADAM R | Officer (Chief Commercial Officer) | Shares withheld for taxes / exercise cost | 25,483 | $4.26 | $108.6K | Form 4 |
| 2026-07-28 | KALBERMATTEN ADAM R | Officer (Chief Commercial Officer) | Option exercise / conversion | 75,000 | — | $0 | Form 4 |
| 2026-07-01 | KALBERMATTEN ADAM R | Officer (President and CEO) | Grant / award / vesting (derivative) | 284,091 | — | $0 | Form 4/A |
| 2026-07-01 | KALBERMATTEN ADAM R | Officer (President and CEO) | Grant / award / vesting (derivative) | 286,697 | — | $0 | Form 4 |
| 2026-07-01 | CASCELLA ROBERT | Director | Grant / award / vesting | 3,571 | $4.20 | $15.0K | Form 4 |
| 2026-07-01 | FLETCHER R JOHN | Director, Other | Grant / award / vesting | 5,357 | $4.20 | $22.5K | Form 4 |
| 2026-07-01 | French Donna | Director | Grant / award / vesting | 3,571 | $4.20 | $15.0K | Form 4 |
| 2026-07-01 | Matin Shahriar | Director | Grant / award / vesting | 3,571 | $4.20 | $15.0K | Form 4 |
| 2026-07-01 | WHOLIHAN EDWARD | Director | Grant / award / vesting | 3,571 | $4.20 | $15.0K | Form 4 |
| 2026-06-30 | Manko Joseph M. Jr.; Horton Capital Management, LLC; Horton Capital Partners, LLC; Horton Capital Partners Fund, L.P. | Director, 10% owner | Grant / award / vesting | 3,571 | — | $0 | Form 4 |
| 2026-06-11 | KALBERMATTEN ADAM R | Officer (President-Chief Commercial Off) | Open-market purchase | 7,500 | $3.93 | $29.5K | Form 4 |
| 2026-06-11 | KALBERMATTEN ADAM R | Officer (President-Chief Commercial Off) | Open-market purchase | 5,000 | $3.96 | $19.8K | Form 4 |
| 2026-05-18 | Schiller Eric | Officer (Chief Technology Officer) | Open-market purchase | 5,000 | $3.91 | $19.6K | Form 4 |
| 2026-05-15 | Tharby Linda M | Director, Officer (Chief Executive Officer) | Open-market purchase | 1,191 | $1,191.00 | $1.42M | Form 4 |
| 2026-05-15 | Tharby Linda M | Director, Officer (Chief Executive Officer) | Open-market purchase | 1,191 | $3.92 | $4.7K | Form 4/A |
| 2026-05-14 | Tharby Linda M | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 7,326 | $3.94 | $28.9K | Form 4 |
| 2026-05-14 | Tharby Linda M | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 13,977 | — | $0 | Form 4 |
| 2026-05-14 | Adams Thomas Edward | Officer (Chief Financial Officer) | Open-market purchase | 459 | $3.90 | $1.8K | Form 4 |
| 2026-05-14 | Adams Thomas Edward | Officer (Chief Financial Officer) | Open-market purchase | 5,041 | $3.86 | $19.5K | Form 4 |
| 2026-05-14 | Adams Thomas Edward | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 2,900 | $3.94 | $11.4K | Form 4 |
| 2026-05-14 | Adams Thomas Edward | Officer (Chief Financial Officer) | Option exercise / conversion | 8,193 | — | $0 | Form 4 |
| 2026-05-14 | Pazdan Christopher | Officer (Chief Operating Officer) | Open-market purchase | 5,000 | $3.88 | $19.4K | Form 4 |
| 2026-05-14 | Pazdan Christopher | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 1,470 | $3.94 | $5.8K | Form 4 |
| 2026-05-14 | Pazdan Christopher | Officer (Chief Operating Officer) | Option exercise / conversion | 5,327 | — | $0 | Form 4 |
Ask the chat about KRMD's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: KORU MEDICAL SYSTEMS INC (KRMD).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.